Literature DB >> 25989301

Comparison of Traditional versus Normative Cephalic Index in Patients with Sagittal Synostosis: Measure of Scaphocephaly and Postoperative Outcome.

Lucas A Dvoracek1, Gary B Skolnick, Dennis C Nguyen, Sybill D Naidoo, Matthew D Smyth, Albert S Woo, Kamlesh B Patel.   

Abstract

BACKGROUND: Preoperative severity and postoperative success for patients with sagittal synostosis are measured by cephalic index, but this metric does not describe the appropriateness of euryon location. The authors hypothesize that cephalic index in patients with sagittal synostosis is an inaccurate measure of scaphocephaly.
METHODS: Preoperative and 1-year postoperative cranial computed tomographic scans of children with sagittal synostosis treated before 6 months of age by either total calvarial reconstruction or endoscope-assisted craniectomy and helmet therapy (n = 10 for each) were reviewed retrospectively. The location of euryons in age-matched controls was measured as a fraction of the glabella-opisthocranion distance (horizontal point of maximum width) and as the fraction of the nasion-vertex vertical distance (vertical point of maximum width). Cephalic index at this ideal location (normative cephalic index) and traditional cephalic index were determined in all patients.
RESULTS: Ideal euryon location from preoperative controls was 56 percent by the horizontal point of maximum width and 56 percent by the vertical point of maximum width. Normative cephalic index (0.60) was significantly less than traditional cephalic index (0.66) in patients preoperatively (p < 0.001) and remained smaller postoperatively (0.68 versus 0.73) for patients who underwent open reconstruction (p < 0.001). Patients treated endoscopically also had a smaller normative cephalic index (0.71) than traditional cephalic index (0.76) postoperatively (p < 0.001).
CONCLUSIONS: Anterocaudal displacement of euryon in patients with sagittal synostosis influences cephalic index. Normative cephalic index, assessed at ideal euryon location, is a more accurate measure of preoperative severity and postoperative outcome. CLINICAL QUESTION/LEVEL OF EVIDENCE: Diagnostic, III.

Entities:  

Mesh:

Year:  2015        PMID: 25989301     DOI: 10.1097/PRS.0000000000001505

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  Comparison of Resorbable Plating Systems: Complications During Degradation.

Authors:  Dennis C Nguyen; Albert S Woo; Scott J Farber; Gary B Skolnick; Jenny Yu; Sybill D Naidoo; Kamlesh B Patel
Journal:  J Craniofac Surg       Date:  2017-01       Impact factor: 1.046

2.  The unseen third dimension: a novel approach for assessing head shape severity in infants with isolated sagittal synostosis.

Authors:  Rosalinda Calandrelli; Fabio Pilato; Luca Massimi; Marco Panfili; Concezio Di Rocco; Cesare Colosimo
Journal:  Childs Nerv Syst       Date:  2019-06-12       Impact factor: 1.475

3.  Occult Scaphocephaly: A Forme Fruste Phenotype of Sagittal Craniosynostosis.

Authors:  Esperanza Mantilla-Rivas; Liyun Tu; Agnes Goldrich; Monica Manrique; Antonio R Porras; Robert F Keating; Albert K Oh; Marius George Linguraru; Gary F Rogers
Journal:  J Craniofac Surg       Date:  2020 Jul-Aug       Impact factor: 1.046

4.  Cranial growth in isolated sagittal craniosynostosis compared with normal growth in the first 6 months of age.

Authors:  Ezgi Mercan; Richard A Hopper; A Murat Maga
Journal:  J Anat       Date:  2019-11-06       Impact factor: 2.610

5.  Evaluating Surgical Decision-making in Nonsyndromic Sagittal Craniosynostosis Using a Digital 3D Model.

Authors:  Christopher D Hughes; Olivia Langa; Laura Nuzzi; Steven J Staffa; Mark Proctor; John G Meara; Ingrid M Ganske
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-05-21

6.  Modification of the Melbourne Method for Total Calvarial Vault Remodeling.

Authors:  Christopher D Hughes; Kathryn V Isaac; Paul F Hwang; Ingrid Ganske; Mark R Proctor; John G Meara
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.